Cite
Estimation of the Standardized Risk Difference and Ratio in a Competing Risks Framework: Application to Injection Drug Use and Progression to AIDS After Initiation of Antiretroviral Therapy.
MLA
Cole, Stephen R., et al. “Estimation of the Standardized Risk Difference and Ratio in a Competing Risks Framework: Application to Injection Drug Use and Progression to AIDS After Initiation of Antiretroviral Therapy.” American Journal of Epidemiology, vol. 181, no. 4, Feb. 2015, pp. 238–45. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=101033180&authtype=sso&custid=ns315887.
APA
Cole, S. R., Lau, B., Eron, J. J., Brookhart, M. A., Kitahata, M. M., Martin, J. N., Mathews, W. C., & Mugavero, M. J. (2015). Estimation of the Standardized Risk Difference and Ratio in a Competing Risks Framework: Application to Injection Drug Use and Progression to AIDS After Initiation of Antiretroviral Therapy. American Journal of Epidemiology, 181(4), 238–245.
Chicago
Cole, Stephen R., Bryan Lau, Joseph J. Eron, M. Alan Brookhart, Mari M. Kitahata, Jeffrey N. Martin, William C. Mathews, and Michael J. Mugavero. 2015. “Estimation of the Standardized Risk Difference and Ratio in a Competing Risks Framework: Application to Injection Drug Use and Progression to AIDS After Initiation of Antiretroviral Therapy.” American Journal of Epidemiology 181 (4): 238–45. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=101033180&authtype=sso&custid=ns315887.